Daniel B. Mark

Q: What Schools Are Affiliated With Daniel B. Mark

Daniel B. Mark is affiliated with the following schools: University of California, Berkeley, Uppsala University, Emory University, Stanford University, Johns Hopkins University, University of Toronto, Duke University

Daniel B. Mark's AcademicInfluence.com Rankings

Daniel B. Mark

Computer Science

#3206

World Rank

#3359

Historical Rank

Machine Learning

#324

World Rank

#328

Historical Rank

Artificial Intelligence

#510

World Rank

#519

Historical Rank

Database

#671

World Rank

#703

Historical Rank

computer-science Degrees

Download Badge

Computer Science

Daniel B. Mark's Degrees

PhD Computer Science Stanford University
Masters Computer Science University of California, Berkeley
Bachelors Computer Science University of California, Berkeley

Similar Degrees You Can Earn

Why Is Daniel B. Mark Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Daniel B. Mark's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. (1996) (8495)
Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. (2005) (5925)
ACC/AHA 2002 guideline update for exercise testing: summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1997 Exercise Testing Guidelines). (2002) (2258)
Longitudinal assessment of neurocognitive function after coronary-artery bypass surgery. (2001) (1768)
A brief self-administered questionnaire to determine functional capacity (the Duke Activity Status Index). (1989) (1415)
ACC/AHA 2002 guideline update for exercise testing: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1997 Exercise Testing Guidelines). (2002) (1400)
Prognostic importance of defibrillator shocks in patients with heart failure. (2008) (1341)
Depression and coronary heart disease: recommendations for screening, referral, and treatment: a science advisory from the American Heart Association Prevention Committee of the Council on Cardiovascular Nursing, Council on Clinical Cardiology, Council on Epidemiology and Prevention, and Interdiscip (2008) (1284)
Outcomes of anatomical versus functional testing for coronary artery disease. (2015) (1126)
Initial Invasive or Conservative Strategy for Stable Coronary Disease. (2020) (1071)
ACC/AHA guidelines for exercise testing: executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Exercise Testing). (1997) (1010)
Clopidogrel use and long-term clinical outcomes after drug-eluting stent implantation. (2007) (926)
ACCF/SCCT/ACR/AHA/ASE/ASNC/NASCI/SCAI/SCMR 2010 Appropriate Use Criteria for Cardiac Computed Tomography. A Report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, the Society of Cardiovascular Computed Tomography, the American College of Radiology, the American (2010) (828)
Prognostic value of a treadmill exercise score in outpatients with suspected coronary artery disease. (1991) (814)
Effect of Catheter Ablation vs Antiarrhythmic Drug Therapy on Mortality, Stroke, Bleeding, and Cardiac Arrest Among Patients With Atrial Fibrillation: The CABANA Randomized Clinical Trial (2019) (800)
ACC/AHA Guidelines for Exercise Testing. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Exercise Testing). (1997) (723)
Discordance of Databases Designed for Claims Payment versus Clinical Information Systems: Implications for Outcomes Research (1993) (654)
Exercise treadmill score for predicting prognosis in coronary artery disease. (1987) (641)
Coronary intervention for persistent occlusion after myocardial infarction. (2006) (599)
Prognostic importance of social and economic resources among medically treated patients with angiographically documented coronary artery disease. (1992) (560)
Cost effectiveness of thrombolytic therapy with tissue plasminogen activator as compared with streptokinase for acute myocardial infarction. (1995) (534)
Depression and long-term mortality risk in patients with coronary artery disease. (1996) (526)
Racial variation in the use of coronary-revascularization procedures. Are the differences real? Do they matter? (1997) (523)
Cardiac resynchronization therapy: Part 1--issues before device implantation. (2005) (505)
Prognostic value of a coronary artery jeopardy score. (1985) (464)
Continuing evolution of therapy for coronary artery disease. Initial results from the era of coronary angioplasty. (1994) (421)
Depression as a risk factor for mortality after coronary artery bypass surgery (2003) (416)
Characteristics of Socially Isolated Patients With Coronary Artery Disease Who Are at Elevated Risk for Mortality (2001) (415)
Diagnosing and managing unstable angina. Agency for Health Care Policy and Research. (1994) (396)
Factors affecting sensitivity and specificity of exercise electrocardiography. Multivariable analysis. (1984) (383)
Palliative Care in Heart Failure: The PAL-HF Randomized, Controlled Clinical Trial. (2017) (369)
Report of the Substudy Assessing the Impact of Neurocognitive Function on Quality of Life 5 Years After Cardiac Surgery (2001) (359)
Use of medical resources and quality of life after acute myocardial infarction in Canada and the United States. (1994) (357)
Severity of renal vascular disease predicts mortality in patients undergoing coronary angiography. (2001) (357)
ACCF/SCCT/ACR/AHA/ASE/ASNC/NASCI/SCAI/SCMR 2010 appropriate use criteria for cardiac computed tomography. A report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, the Society of Cardiovascular Computed Tomography, the American College of Radiology, the American (2010) (350)
ACC/AHA statement on cost/value methodology in clinical practice guidelines and performance measures: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures and Task Force on Practice Guidelines. (2014) (348)
Effect of Natriuretic Peptide–Guided Therapy on Hospitalization or Cardiovascular Mortality in High-Risk Patients With Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial (2017) (343)
The evolution of medical and surgical therapy for coronary artery disease. A 15-year perspective. (1989) (336)
Regional variation across the United States in the management of acute myocardial infarction. GUSTO-1 Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries. (1995) (333)
Effect of Catheter Ablation vs Medical Therapy on Quality of Life Among Patients With Atrial Fibrillation: The CABANA Randomized Clinical Trial (2019) (332)
Medical care costs and quality of life after randomization to coronary angioplasty or coronary bypass surgery. Bypass Angioplasty Revascularization Investigation (BARI) Investigators. (1997) (331)
Outcomes at 1 year and economic implications of platelet glycoprotein IIb/IIIa blockade in patients undergoing coronary stenting: results from a multicentre randomised trial (1999) (330)
Restenosis after coronary angioplasty: an overview. (1991) (321)
Clinical prediction models: are we building better mousetraps? (2003) (308)
Relationship between diabetes mellitus and long-term survival after coronary bypass and angioplasty. (1997) (300)
Use of a prognostic treadmill score in identifying diagnostic coronary disease subgroups. (1998) (297)
Central nervous system injury associated with cardiac surgery (2006) (295)
The relation between the volume of coronary angioplasty procedures at hospitals treating Medicare beneficiaries and short-term mortality. (1994) (294)
Prognostic Value of Noninvasive Cardiovascular Testing in Patients With Stable Chest Pain: Insights From the PROMISE Trial (Prospective Multicenter Imaging Study for Evaluation of Chest Pain) (2017) (292)
Cardiac rupture, mortality and the timing of thrombolytic therapy: a meta-analysis. (1990) (284)
Cost-Effectiveness of Defibrillator Therapy or Amiodarone in Chronic Stable Heart Failure: Results From the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) (2006) (271)
Long-term survival benefits of coronary artery bypass grafting and percutaneous transluminal angioplasty in patients with coronary artery disease. (1996) (265)
Outcomes of coronary artery bypass graft surgery in 24,461 patients aged 80 years or older. (1995) (264)
Use of High-Risk Coronary Atherosclerotic Plaque Detection for Risk Stratification of Patients With Stable Chest Pain: A Secondary Analysis of the PROMISE Randomized Clinical Trial (2018) (260)
ACCF/ACR/AHA/NASCI/SAIP/SCAI/SCCT 2010 expert consensus document on coronary computed tomographic angiography: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents. (2010) (252)
ACCF/ACR/AHA/NASCI/SAIP/SCAI/SCCT 2010 expert consensus document on coronary computed tomographic angiography: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents. (2010) (249)
Prognostic implications of angiographically normal and insignificantly narrowed coronary arteries. (1986) (248)
Non-evidence-based ICD implantations in the United States. (2011) (247)
Quality of life with defibrillator therapy or amiodarone in heart failure. (2008) (245)
Value of exercise treadmill testing in women. (1998) (241)
Management of Coronary Disease in Patients with Advanced Kidney Disease. (2020) (239)
Chronic kidney disease, mortality, and treatment strategies among patients with clinically significant coronary artery disease. (2003) (233)
Relationship between physician and hospital coronary angioplasty volume and outcome in elderly patients. (1997) (233)
Home use of automated external defibrillators for sudden cardiac arrest. (2008) (231)
ACC/AHA statement on cost/value methodology in clinical practice guidelines and performance measures: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures and Task Force on Practice Guidelines. (2014) (229)
The effects of New York's bypass surgery provider profiling on access to care and patient outcomes in the elderly. (1998) (226)
Maximizing Survival Benefit With Primary Prevention Implantable Cardioverter-Defibrillator Therapy in a Heart Failure Population (2009) (224)
Comparing risk-adjustment methods for provider profiling. (1998) (224)
The primary and secondary prevention of coronary artery disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). (2008) (224)
Health-Status Outcomes with Invasive or Conservative Care in Coronary Disease. (2020) (222)
Impact of Implantable Cardioverter-Defibrillator, Amiodarone, and Placebo on the Mode of Death in Stable Patients With Heart Failure: Analysis From the Sudden Cardiac Death in Heart Failure Trial (2009) (220)
Prognostic value of radionuclide angiography in medically treated patients with coronary artery disease. A comparison with clinical and catheterization variables. (1990) (217)
International Study of Comparative Health Effectiveness with Medical and Invasive Approaches (ISCHEMIA) trial: Rationale and design (2018) (216)
Effect of disodium EDTA chelation regimen on cardiovascular events in patients with previous myocardial infarction: the TACT randomized trial. (2013) (215)
Failure of simple clinical measurements to predict perfusion status after intravenous thrombolysis. (1988) (212)
Cardiac resynchronization therapy: Part 2--issues during and after device implantation and unresolved questions. (2005) (210)
Survival in renal vascular disease. (1998) (209)
Association of Neurocognitive Function and Quality of Life 1 Year After Coronary Artery Bypass Graft (CABG) Surgery (2006) (205)
Referral patterns for coronary artery disease treatment: gender bias or good clinical judgment? (1992) (205)
Prognosis in cardiogenic shock after acute myocardial infarction in the interventional era. (1992) (205)
Depressive Symptoms and Survival of Patients With Coronary Artery Disease (2000) (199)
Outcome of acute myocardial infarction according to the specialty of the admitting physician. (1996) (199)
Role of Microvolt T-Wave Alternans in Assessment of Arrhythmia Vulnerability Among Patients With Heart Failure and Systolic Dysfunction: Primary Results From the T-Wave Alternans Sudden Cardiac Death in Heart Failure Trial Substudy (2008) (190)
The prognostic importance of comorbidity for mortality in patients with stable coronary artery disease. (2004) (190)
The rationale and design of the Surgical Treatment for Ischemic Heart Failure (STICH) trial. (2007) (190)
Comparison of predictions based on observational data with the results of randomized controlled clinical trials of coronary artery bypass surgery. (1988) (185)
Educational and Psychological Interventions to Improve Outcomes for Recipients of Implantable Cardioverter Defibrillators and Their Families: A Scientific Statement From the American Heart Association (2012) (183)
Economic assessment of low-molecular-weight heparin (enoxaparin) versus unfractionated heparin in acute coronary syndrome patients: results from the ESSENCE randomized trial. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q wave Coronary Events [unstable angina or non-Q-wave myocardial infarc (1998) (176)
Importance of clinical measures of ischemia in the prognosis of patients with documented coronary artery disease. (1988) (175)
Absence of sex bias in the referral of patients for cardiac catheterization. (1994) (174)
Music, imagery, touch, and prayer as adjuncts to interventional cardiac care: the Monitoring and Actualisation of Noetic Trainings (MANTRA) II randomised study (2005) (173)
A national survey of provisions in clinical-trial agreements between medical schools and industry sponsors. (2002) (172)
Risk of Thromboembolism in Heart Failure: An Analysis From the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) (2007) (169)
Enhancing Recovery in Coronary Heart Disease (ENRICHD) Study Intervention: Rationale and Design (2001) (167)
Changes in Mortality after Myocardial Revascularization in the Elderly: The National Medicare Experience (1994) (165)
Surgical survival benefits for coronary disease patients with left ventricular dysfunction. (1988) (161)
Outcome in suspected acute myocardial infarction with normal or minimally abnormal admission electrocardiographic findings. (1987) (159)
Determinants of early versus late cardiac death in patients undergoing coronary artery bypass graft surgery. (1991) (159)
Noninvasive FFR Derived From Coronary CT Angiography: Management and Outcomes in the PROMISE Trial. (2017) (157)
Evolution of the coronary care unit: Clinical characteristics and temporal trends in healthcare delivery and outcomes* (2010) (153)
No benefit from defibrillation threshold testing in the SCD-HeFT (Sudden Cardiac Death in Heart Failure Trial). (2008) (152)
Characteristics and consequences of myocardial infarction after percutaneous coronary intervention: insights from the Coronary Angioplasty Versus Excisional Atherectomy Trial (CAVEAT). (1995) (150)
Relation of clinical and angiographic factors to functional capacity as measured by the Duke Activity Status Index. (1991) (150)
Importance of baseline functional and socioeconomic factors for participation in cardiac rehabilitation. (1995) (148)
The value of estimated functional capacity in estimating outcome: results from the NHBLI-Sponsored Women's Ischemia Syndrome Evaluation (WISE) Study. (2006) (145)
Economic assessment of platelet glycoprotein IIb/IIIa inhibition for prevention of ischemic complications of high-risk coronary angioplasty. EPIC Investigators. (1996) (144)
Cost effectiveness of early discharge after uncomplicated acute myocardial infarction. (2000) (141)
Usefulness of psychosocial treatment of mental stress-induced myocardial ischemia in men. (2002) (141)
2020 ACC/AHA guideline for the management of patients with valvular heart disease: A report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. (2021) (141)
Prospective Randomized Trial of Normothermic versus Hypothermic Cardiopulmonary Bypass on Cognitive Function after Coronary Artery Bypass Graft Surgery (2001) (140)
Estimating the likelihood of severe coronary artery disease. (1991) (140)
Coronary perfusion during acute myocardial infarction with a combined therapy of coronary angioplasty and high-dose intravenous streptokinase. (1988) (138)
Early discharge in the thrombolytic era: an analysis of criteria for uncomplicated infarction from the Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries (GUSTO) trial. (1996) (138)
Ablation Versus Drug Therapy for Atrial Fibrillation in Heart Failure (2021) (135)
The association between self-rated health and mortality in a well-characterized sample of coronary artery disease patients. (1999) (129)
Medical economics and the assessment of value in cardiovascular medicine: Part I. (2002) (129)
Costs for heart failure with normal vs reduced ejection fraction. (2006) (128)
Clinical characteristics and long-term survival of patients with variant angina. (1984) (127)
Myocardial Viability and Long-Term Outcomes in Ischemic Cardiomyopathy. (2019) (125)
Natriuretic peptides in the diagnosis and management of heart failure (2006) (125)
Clinical and Economic Implications of the Multicenter Automatic Defibrillator Implantation Trial-II (2005) (125)
Hostility as a Predictor of Survival in Patients With Coronary Artery Disease (2004) (124)
Cost-effectiveness of platelet glycoprotein IIb/IIIa inhibition with eptifibatide in patients with non-ST-elevation acute coronary syndromes. (2000) (123)
Detection of restenosis after elective percutaneous transluminal coronary angioplasty using the exercise treadmill test. (1990) (123)
Medical Costs and Quality of Life 10 to 12 Years After Randomization to Angioplasty or Bypass Surgery for Multivessel Coronary Artery Disease (2004) (123)
Heavy Metals, Cardiovascular Disease, and the Unexpected Benefits of Chelation Therapy. (2016) (120)
PROspective Multicenter Imaging Study for Evaluation of chest pain: rationale and design of the PROMISE trial. (2014) (120)
Job strain and the prevalence and outcome of coronary artery disease. (1995) (120)
Rationale and design of the GUIDE-IT study: Guiding Evidence Based Therapy Using Biomarker Intensified Treatment in Heart Failure. (2014) (119)
Distinguishing between early and late responders to symptoms of acute myocardial infarction. (1995) (117)
Social support and quality of life in patients with coronary artery disease (2004) (117)
Peripheral vascular complications in the Coronary Angioplasty Versus Excisional Atherectomy Trial (CAVEAT-I). (1995) (116)
ACCF/ACR/AHA/NASCI/SAIP/SCAI/SCCT 2010 Expert Consensus Document on Coronary Computed Tomographic Angiography (2010) (115)
Clopidogrel use and bleeding after coronary artery bypass graft surgery. (2008) (115)
Social Support and Hostility as Predictors of Depressive Symptoms in Cardiac Patients One Month After Hospitalization: A Prospective Study (1998) (114)
Outcomes of noncardiac surgery after coronary bypass surgery or coronary angioplasty in the Bypass Angioplasty Revascularization Investigation (BARI). (2001) (113)
Sex Differences in Demographics, Risk Factors, Presentation, and Noninvasive Testing in Stable Outpatients With Suspected Coronary Artery Disease: Insights From the PROMISE Trial. (2016) (112)
Comparison of analytic models for estimating the effect of clinical factors on the cost of coronary artery bypass graft surgery. (1993) (111)
Exercise capacity: the prognostic variable that doesn't get enough respect. (2003) (110)
Catheter Ablation versus Antiarrhythmic Drug Therapy for Atrial Fibrillation (CABANA) Trial: Study Rationale and Design (2018) (106)
Stroke and acute myocardial infarction in the thrombolytic era: clinical correlates and long-term prognosis. (1990) (105)
Bleeding during thrombolytic therapy for acute myocardial infarction: mechanisms and management. (1989) (105)
Syncope predicts the outcome of cardiomyopathy patients: analysis of the SCD-HeFT study. (2008) (104)
Long-term costs and resource use in elderly participants with congestive heart failure in the Cardiovascular Health Study. (2007) (103)
Thyroid function in heart failure and impact on mortality. (2013) (102)
Female Gender Is Associated With Impaired Quality of Life 1 Year After Coronary Artery Bypass Surgery (2003) (98)
AHA science advisory. Depression and coronary heart disease. Recommendations for screening, referral, and treatment. A science advisory from the American Heart Association Prevention Committee to the Council on Cardiovascular Nursing, Council on Clinical Cardiology, Council on Epidemiology and Preve (2009) (96)
Thrombotic and cardiovascular complications related to nonionic contrast media during cardiac catheterization: analysis of 8,517 patients. (1990) (96)
B-type natriuretic peptide - a biomarker for all seasons? (2004) (96)
Survival of patients receiving a primary prevention implantable cardioverter-defibrillator in clinical practice vs clinical trials. (2013) (95)
Comparison of time domain and frequency domain variables from the signal-averaged electrocardiogram: a multivariable analysis. (1988) (95)
Baseline Characteristics and Risk Profiles of Participants in the ISCHEMIA Randomized Clinical Trial (2019) (95)
Ergonovine maleate testing during cardiac catheterization: a 10-year perspective in 3,447 patients without significant coronary artery disease or Prinzmetal's variant angina. (1992) (94)
Clinical data bases. Accomplishments and unrealized potential. (1985) (93)
Statin use was associated with reduced mortality in both ischemic and nonischemic cardiomyopathy and in patients with implantable defibrillators: mortality data and mechanistic insights from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT). (2007) (92)
Effect of smoking and sedentary behavior on the association between depressive symptoms and mortality from coronary heart disease. (2003) (92)
Survival Benefit of the Primary Prevention Implantable Cardioverter-Defibrillator Among Older Patients: Does Age Matter? An Analysis of Pooled Data From 5 Clinical Trials (2015) (90)
34th Bethesda Conference: Can atherosclerosis imaging techniques improve the detection of patients at risk for ischemic heart disease? (2003) (90)
Conducting economic evaluations alongside multinational clinical trials: toward a research consensus. (2005) (90)
Assessing the Clinical and Economic Burden of Coronary Artery Disease: 1986-1998 (2001) (89)
Measuring and improving quality of care: a report from the American Heart Association/American College of Cardiology First Scientific Forum on Assessment of Healthcare Quality in Cardiovascular Disease and Stroke. (2000) (89)
Implantable cardioverter-defibrillators for primary prevention of sudden cardiac death in CKD: a meta-analysis of patient-level data from 3 randomized trials. (2014) (88)
The Effect of an EDTA-based Chelation Regimen on Patients With Diabetes Mellitus and Prior Myocardial Infarction in the Trial to Assess Chelation Therapy (TACT) (2014) (88)
Cognitive function 5 years after randomization to coronary angioplasty or coronary artery bypass graft surgery. (1997) (88)
Observational Comparison of Event‐Free Survival With Medical and Surgical Therapy in Patients With Coronary Artery Disease: 20 Years of Follow‐up (1992) (86)
Perceived Social Support as a Predictor of Mortality in Coronary Patients: Effects of Smoking, Sedentary Behavior, and Depressive Symptoms (2005) (85)
Identification of Patients With Coronary Disease at High Risk for Loss of Employment: A Prospective Validation Study (1992) (83)
Impact of rate-modulated pacing on quality of life and exercise capacity--evidence from the Advanced Elements of Pacing Randomized Controlled Trial (ADEPT). (2007) (82)
Diagnosing and managing unstable angina. Agency for Health Care Policy and Research. (1994) (81)
Resource use and cost of initial coronary revascularization. Coronary angioplasty versus coronary bypass surgery. (1990) (80)
Recurrence of Atrial Fibrillation After Catheter Ablation or Antiarrhythmic Drug Therapy in the CABANA Trial. (2020) (80)
Enhancing recovery in coronary heart disease (ENRICHD): baseline characteristics. (2001) (78)
Primary Prevention with Defibrillator Therapy in Women: Results from the Sudden Cardiac Death in Heart Failure Trial (2008) (78)
Outcomes in the ISCHEMIA Trial Based on Coronary Artery Disease and Ischemia Severity (2021) (77)
Outcomes of implantable cardioverter-defibrillator use in patients with comorbidities: results from a combined analysis of 4 randomized clinical trials. (2014) (77)
Localizing coronary artery obstructions with the exercise treadmill test. (1987) (77)
Poverty, process of care, and outcome in acute coronary syndromes. (2003) (77)
Measuring and improving quality of care : A report from the american heart Association/American college of cardiology first scientific forum on assessment of healthcare quality in cardiovascular disease and stroke (2000) (77)
Facets of Openness Predict Mortality in Patients With Cardiac Disease (2007) (75)
Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure (2005) (75)
Primary Prevention Implantable Cardioverter Defibrillators in Patients With Nonischemic Cardiomyopathy: A Meta-analysis (2017) (74)
Association between bleeding, blood transfusion, and costs among patients with non-ST-segment elevation acute coronary syndromes. (2008) (74)
International differences in evolution of early discharge after acute myocardial infarction (2004) (74)
Painless exercise ST deviation on the treadmill: long-term prognosis. (1989) (74)
Acute and long-term cost implications of coronary stenting. (1999) (73)
Implantable cardioverter defibrillators and cardiac resynchronization therapy in patients with left ventricular dysfunction: randomized trial evidence through 2004. (2005) (73)
Long-Term Mortality of Patients With Acute Myocardial Infarction in the United States and Canada: Comparison of Patients Enrolled in Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries (GUSTO)-I (2004) (72)
2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure. (2022) (71)
Impact of lung transplantation on recipient quality of life: a serial, prospective, multicenter analysis through the first posttransplant year. (2013) (71)
Tying clinical research to patient care by use of an observational database. (1984) (71)
Design of the Trial to Assess Chelation Therapy (TACT). (2012) (70)
Sex Differences in Functional and CT Angiography Testing in Patients With Suspected Coronary Artery Disease. (2016) (69)
Design and methodology of the Occluded Artery Trial (OAT). (2005) (69)
Identification of Patients With Stable Chest Pain Deriving Minimal Value From Noninvasive Testing: The PROMISE Minimal-Risk Tool, A Secondary Analysis of a Randomized Clinical Trial (2017) (68)
Perception of cognitive function in older adults following coronary artery bypass surgery. (1999) (67)
Recovery expectations and long-term prognosis of patients with coronary heart disease. (2011) (67)
Medical, psychological and social correlates of work disability among men with coronary artery disease. (1986) (67)
Catheter Ablation for Ventricular Tachycardia in Patients with an Implantable Cardioverter Defibrillator (CALYPSO) Pilot Trial (2015) (64)
Trends in physician management of uncomplicated acute myocardial infarction, 1970 to 1987. (1988) (64)
Identification of Acute Myocardial Infarction Patients Suitable for Early Hospital Discharge After Aggressive Interventional Therapy: Results From the Thrombolysis and Angioplasty in Acute Myocardial Infarction Registry (1991) (63)
Adoption of thrombolytic therapy in the management of acute myocardial infarction. (1988) (62)
Clinical experience and predicting survival in coronary disease. (1989) (61)
The changing survival benefits of coronary revascularization over time. (1987) (60)
An ECG index of myocardial scar enhances prediction of defibrillator shocks: an analysis of the Sudden Cardiac Death in Heart Failure Trial. (2011) (60)
Economic impact of drug-eluting stents on hospital systems: a disease-state model. (2004) (60)
Effects of Coronary Angioplasty, Coronary Bypass Surgery, and Medical Therapy on Employment in Patients with Coronary Artery Disease: A Prospective Comparison Study (1994) (60)
Intraoperative Magnesium Administration Does Not Improve Neurocognitive Function After Cardiac Surgery (2013) (60)
The Primary and Secondary Prevention of Coronary Artery Disease (2008) (59)
Differences in the Treatment of Myocardial Infarction Between the United States and Canada: A Survey of Physicians in the GUSTO Trial (1995) (59)
Electrocardiographic differentiation of the ST-segment depression of acute myocardial injury due to the left circumflex artery occlusion from that of myocardial ischemia of nonocclusive etiologies. (1997) (59)
NT-proBNP Goal Achievement Is Associated With Significant Reverse Remodeling and Improved Clinical Outcomes in HFrEF. (2019) (59)
The Relationship between Self-Rated Health and Health Status among Coronary Artery Patients (1999) (59)
Obesity and long-term clinical and economic outcomes in coronary artery disease patients. (2002) (58)
Prognostic value of the simplified Selvester QRS score in patients with coronary artery disease. (1988) (57)
No benefit of a dual coil over a single coil ICD lead: evidence from the Sudden Cardiac Death in Heart Failure Trial. (2013) (57)
Preventing tomorrow's sudden cardiac death today: dissemination of effective therapies for sudden cardiac death prevention. (2008) (57)
Exercise treadmill testing is a poor predictor of anatomic restenosis after angioplasty for acute myocardial infarction. (1989) (57)
Ratings of positive and depressive emotion as predictors of mortality in coronary patients. (2005) (57)
Treatment with adenosine diphosphate receptor inhibitors-longitudinal assessment of treatment patterns and events after acute coronary syndrome (TRANSLATE-ACS) study design: expanding the paradigm of longitudinal observational research. (2011) (56)
Canadian-American Differences in the Management of Acute Coronary Syndromes in the GUSTO IIb Trial: One-Year Follow-Up of Patients Without ST-Segment Elevation (2000) (55)
Helicopter transport of patients during acute myocardial infarction. (1988) (55)
Oral High-Dose Multivitamins and Minerals After Myocardial Infarction (2013) (55)
Rapid-rate nonsustained ventricular tachycardia found on implantable cardioverter-defibrillator interrogation: relationship to outcomes in the SCD-HeFT (Sudden Cardiac Death in Heart Failure Trial). (2013) (55)
Time-based risk assessment after myocardial infarction. Implications for timing of discharge and applications to medical decision-making. (2003) (55)
Rethinking sensitivity and specificity. (1987) (54)
Impact of early discharge after coronary artery bypass graft surgery on rates of hospital readmission and death. The Ischemic Heart Disease (IHD) Patient Outcomes Research Team (PORT) Investigators. (1997) (54)
The Metabolic Syndrome and Risk of Sudden Cardiac Death: The Atherosclerosis Risk in Communities Study (2017) (54)
Ejection fraction assessment and survival: an analysis of the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT). (2008) (53)
Assessment of Limitations to Optimization of Guideline-Directed Medical Therapy in Heart Failure From the GUIDE-IT Trial: A Secondary Analysis of a Randomized Clinical Trial. (2020) (53)
The effects of exercise on cardiovascular biomarkers in patients with chronic heart failure. (2014) (53)
Moderators of the effect of social support on depressive symptoms in cardiac patients. (2000) (53)
Myocardial infarction following coronary artery bypass graft surgery increases healthcare resource utilization (2007) (52)
Effects of Ranolazine on Angina and Quality of Life After Percutaneous Coronary Intervention With Incomplete Revascularization: Results From the Ranolazine for Incomplete Vessel Revascularization (RIVER-PCI) Trial (2016) (52)
Hostility, age, and mortality in a sample of cardiac patients. (2005) (52)
Implantable Cardioverter Defibrillator Therapy in Patients with Prior Coronary Revascularization in the Sudden Cardiac Death in Heart Failure Trial (SCD‐HeFT) (2008) (52)
ACC/AHA/ASE/ASNC/HRS/IAC/Mended Hearts/NASCI/RSNA/SAIP/SCAI/SCCT/SCMR/SNMMI 2014 health policy statement on use of noninvasive cardiovascular imaging: a report of the American College of Cardiology Clinical Quality Committee. (2014) (51)
Protecting the brain in coronary artery bypass graft surgery. (2002) (51)
Assessment of activity status and survival according to the Canadian Cardiovascular Society angina classification. (2009) (51)
Clinical and research issues regarding chronic advanced coronary artery disease part II: Trial design, outcomes, and regulatory issues. (2008) (51)
Late restenosis after emergent coronary angioplasty for acute myocardial infarction: comparison with elective coronary angioplasty. (1988) (50)
Preventing tomorrow's sudden cardiac death today: part I: Current data on risk stratification for sudden cardiac death. (2007) (50)
Diagnosis-to-Ablation Time and Recurrence of Atrial Fibrillation Following Catheter Ablation (2020) (50)
Acute Coronary Care In The Thrombolytic Era (1995) (50)
Acute Coronary Care (1985) (49)
34th Bethesda Conference: Task force #5--Is atherosclerosis imaging cost effective? (2003) (49)
Geographic variation in resource use for coronary artery bypass surgery. IHD Port Investigators. (1997) (48)
Understanding the Role of P Values and Hypothesis Tests in Clinical Research. (2016) (48)
A new anatomic score for prognosis after cardiac catheterization in patients with previous bypass surgery. (2005) (47)
Clinical judgment and therapeutic decision making. (1990) (47)
Outcome in African Americans and other minorities in the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT). (2008) (47)
Quality of life after late invasive therapy for occluded arteries. (2009) (46)
Accuracy of Medical Claims for Identifying Cardiovascular and Bleeding Events After Myocardial Infarction: A Secondary Analysis of the TRANSLATE-ACS Study (2017) (46)
Employment after Coronary Angioplasty or Coronary Bypass Surgery in Patients Employed at the Time of Revascularization (1998) (46)
International Study of Comparative Health Effectiveness with Medical and Invasive Approaches–Chronic Kidney Disease (ISCHEMIA‐CKD): Rationale and design (2018) (45)
Health Status after Invasive or Conservative Care in Coronary and Advanced Kidney Disease. (2020) (45)
Impact of an interactive video on decision making of patients with ischemic heart disease (1996) (45)
Assessing quality-of-life outcomes in cardiovascular clinical research (2016) (44)
Feasibility and cost-saving potential of outpatient cardiac catheterization. (1990) (43)
Reporting and representation of race/ethnicity in published randomized trials. (2009) (43)
Medical economics and the assessment of value in cardiovascular medicine: Part II. (2002) (43)
Economics of treating heart failure. (1997) (42)
Stress Testing Versus CT Angiography in Patients With Diabetes and Suspected Coronary Artery Disease. (2019) (42)
Clinical and research issues regarding chronic advanced coronary artery disease: part I: Contemporary and emerging therapies. (2008) (42)
The External Validity of Prediction Models for the Diagnosis of Obstructive Coronary Artery Disease in Patients With Stable Chest Pain: Insights From the PROMISE Trial. (2017) (42)
A comparison of U.S. and Canadian cardiac catheterization practices in detecting severe coronary artery disease after myocardial infarction: efficiency, yield and long-term implications. (1999) (41)
Is early too early? Effect of shorter stays after bypass surgery. (2007) (41)
EDTA chelation therapy alone and in combination with oral high-dose multivitamins and minerals for coronary disease: The factorial group results of the Trial to Assess Chelation Therapy. (2014) (41)
Outcomes and costs within a disease management program for advanced congestive heart failure. (1998) (41)
Usefulness of a pericardial friction rub after thrombolytic therapy during acute myocardial infarction in predicting amount of myocardial damage. The TAMI Study Group. (1990) (40)
A simplified method to predict occurrence of complete heart block during acute myocardial infarction (1986) (40)
The Impact of New and Emerging Clinical Data on Treatment Strategies for Atrial Fibrillation (2010) (39)
Exercise capacity and mortality in patients with ischemic left ventricular dysfunction randomized to coronary artery bypass graft surgery or medical therapy: an analysis from the STICH trial (Surgical Treatment for Ischemic Heart Failure). (2014) (39)
Prospective Study of Perceived Stress in Cardiac Patients (2004) (39)
Variant angina and spontaneous coronary artery dissection. (1985) (39)
Changing efficacy of coronary revascularization. Implications for patient selection. (1988) (39)
Mortality benefits from implantable cardioverter-defibrillator therapy are not restricted to patients with remote myocardial infarction: an analysis from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT). (2011) (39)
Prediction of early recurrent myocardial ischemia and coronary reocclusion after successful thrombolysis: a qualitative and quantitative angiographic study. (1989) (38)
IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (2011) (38)
2020 AHA/ACC guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathy: A report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. (2021) (38)
Long-Term Effects of Percutaneous Coronary Intervention of the Totally Occluded Infarct-Related Artery in the Subacute Phase After Myocardial Infarction (2011) (38)
Changes in Medical Therapy and Lifestyle After Anatomical or Functional Testing for Coronary Artery Disease (2016) (38)
Frequency, significance, and cost of recurrent ischemia after thrombolytic therapy for acute myocardial infarction. TAMI Study Group. (1995) (37)
Cost effectiveness of inpatient initiation of antiarrhythmic therapy for supraventricular tachycardias. (1997) (37)
Comparison of quality-of-life measures after radial versus femoral artery access for cardiac catheterization in women: Results of the Study of Access Site for Enhancement of Percutaneous Coronary Intervention for Women quality-of-life substudy. (2015) (37)
Natriuretic Peptide Response and Outcomes in Chronic Heart Failure With Reduced Ejection Fraction. (2019) (37)
Levosimendan in patients with reduced left ventricular function undergoing isolated coronary or valve surgery. (2020) (37)
Trends in postoperative length of stay after bypass surgery. (2006) (36)
The high cost of implantable defibrillators. (2007) (36)
Quality of life and economic outcomes with surgical ventricular reconstruction in ischemic heart failure: results from the Surgical Treatment for Ischemic Heart Failure trial. (2009) (36)
Variability in cost of coronary bypass surgery in New York State: potential for cost savings. (2002) (36)
Long-term economic outcomes associated with intensive versus moderate lipid-lowering therapy in coronary artery disease: results from the Treating to New Targets (TNT) Trial. (2008) (35)
A simplified method to predict occurrence of complete heart block during acute myocardial infarction. (1987) (35)
Cost-Effectiveness of Follow-Up of Pulmonary Nodules Incidentally Detected on Cardiac Computed Tomographic Angiography in Patients With Suspected Coronary Artery Disease (2014) (34)
Implications of cost in treatment selection for patients with coronary heart disease. (1996) (34)
Where patients with mild to moderate heart failure die: results from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT). (2007) (34)
Unexpected deviation in circadian variation of ventricular arrhythmias: the SCD-HeFT (Sudden Cardiac Death in Heart Failure Trial). (2014) (34)
Planning the Safety of Atrial Fibrillation Ablation Registry Initiative (SAFARI) as a Collaborative Pan-Stakeholder Critical Path Registry Model: a Cardiac Safety Research Consortium "Incubator" Think Tank. (2010) (34)
Empirical estimation of life expectancy from large clinical trials: Use of left‐truncated, right‐censored survival analysis methodology (2008) (34)
Absence of bilateral vision loss from amiodarone: a randomized trial. (2007) (32)
Economic Assessment of Platelet Glycoprotein IIb/IIIa Receptor Blockade With Abciximab and Low-Dose Heparin During Percutaneous Coronary Revascularization: Results From the EPILOG Randomized Trial (2000) (32)
Sex bias in cardiovascular care: should women be treated more like men? (2000) (32)
Cardiovascular disease on a global scale: defining the path forward for research and practice. (2007) (32)
Quality-of-Life Outcomes With Anatomic Versus Functional Diagnostic Testing Strategies in Symptomatic Patients With Suspected Coronary Artery Disease: Results From the PROMISE Randomized Trial (2016) (32)
The chest-pain unit--ready for prime time? (1998) (32)
Do income level and race influence survival in patients receiving hemodialysis? (2009) (31)
Better functional status in American than Canadian patients with heart disease: an effect of medical care? (1995) (31)
Clinical correlates of the initial and long-term cost of coronary bypass surgery and coronary angioplasty. (1999) (31)
Association between prophylactic implantable cardioverter-defibrillators and survival in patients with left ventricular ejection fraction between 30% and 35%. (2014) (31)
Advanced coronary artery disease: Appropriate end points for trials of novel therapies. (2001) (31)
Effects of stroke on medical resource use and costs in acute myocardial infarction. GUSTO I Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries Study. (1999) (30)
Economic analysis of ticagrelor therapy from a U.S. perspective: results from the PLATO study. (2015) (30)
Acute and 1‐Year Hospitalization Costs for Acute Myocardial Infarction Treated With Percutaneous Coronary Intervention: Results From the TRANSLATE‐ACS Registry (2019) (30)
New York Heart Association class and the survival benefit from primary prevention implantable cardioverter defibrillators: A pooled analysis of 4 randomized controlled trials (2017) (30)
Quality-of-Life Outcomes With Coronary Artery Bypass Graft Surgery in Ischemic Left Ventricular Dysfunction (2014) (29)
Impact of residency status on perfusion times and outcomes for coronary artery bypass graft surgery. (2007) (29)
Appropriate Use Criteria ACCF/SCCT/ACR/AHA/ASE/ASNC/NASCI/SCAI/SCMR 2010 Appropriate Use Criteria for Cardiac Computed Tomography (2010) (28)
Primary prevention implantable cardioverter-defibrillators and survival in older women. (2015) (28)
Task force #2--the cost of prevention: can we afford it? Can we afford not to do it? 33rd Bethesda Conference. (2002) (28)
Pericardial effusion after intravenous recombinant tissue-type plasminogen activator for acute myocardial infarction. (1991) (27)
Association Between Sex and Treatment Outcomes of Atrial Fibrillation Ablation Versus Drug Therapy: Results from the CABANA Trial. (2021) (27)
Baseline and 6-month costs of primary angioplasty therapy for acute myocardial infarction: results from the primary angioplasty registry. (1995) (26)
Prospective study of associations among positive emotion and functional status in older patients with coronary artery disease. (2009) (26)
Clinical factors related to morbidity and mortality in high‐risk heart failure patients: the GUIDE‐IT predictive model and risk score (2019) (26)
Role of amiodarone or implantable cardioverter/defibrillator in patients with atrial fibrillation and heart failure. (2006) (25)
Temperature during coronary artery bypass surgery affects quality of life. (2001) (25)
SCD-HeFT: Use of R-R interval statistics for long-term risk stratification for arrhythmic sudden cardiac death. (2015) (25)
Comparison of visual assessment of coronary stenosis with independent quantitative coronary angiography: Findings from the Prospective Multicenter Imaging Study for Evaluation of Chest Pain (PROMISE) trial (2017) (24)
Comparison of Incidence of Left Ventricular Systolic Dysfunction Among Patients With Left Bundle Branch Block Versus Those With Normal QRS Duration. (2017) (24)
Personality and Coping with a Common Stressor: Cardiac Catheterization (2001) (24)
Administration of thrombolytic therapy in the community hospital: established principles and unresolved issues. (1988) (23)
Long-Term Outcomes of Implantable Cardioverter-Defibrillator Therapy in the SCD-HeFT. (2020) (23)
The way of the future redux. (1995) (22)
Quality of life in patients with implantable cardioverter–defibrillator: systematic review of randomized controlled trials (2018) (22)
Implantable cardioverter‐defibrillators in heart failure patients with reduced ejection fraction and diabetes (2018) (22)
Long-term Follow-up in the Sudden Cardiac Death Heart Failure Trial (SCD-HEFT) (2012) (22)
Off-pump bypass surgery--ready for the big dance? (2004) (22)
Use of evidence-based medical therapy in patients undergoing percutaneous coronary revascularization in the United States, Europe, and Canada. Coronary Angioplasty Versus Excisional Atherectomy Trial (CAVEAT-I) and Canadian Coronary Atherectomy Trial (CCAT) investigators. (1997) (22)
Economic implications of the prophylactic use of intraaortic balloon counterpulsation in the setting of acute myocardial infarction. The Randomized IABP Study Group. Intraaortic Balloon Pump. (1997) (22)
Diagnosing and Managing Unstable Angina, Quick Reference Guide for Clinicians (1994) (21)
Quality of life after coronary revascularization in the United States and Canada. (2000) (21)
Cost-effectiveness Analysis of Anatomic vs Functional Index Testing in Patients With Low-Risk Stable Chest Pain (2020) (21)
The economics of heart failure. (2013) (21)
AB24-2: Statin therapy was associated with reduced atrial fibrillation and flutter in heart failure patients in SCD-HeFT (2006) (21)
Association Between Age and Outcomes of Catheter Ablation Versus Medical Therapy for Atrial Fibrillation: Results From the CABANA Trial (2021) (21)
Predictive Model for High-Risk Coronary Artery Disease: Insights From the PROMISE Trial (2019) (21)
Long-term clinical outcomes following coronary stenting. (2008) (20)
Relation between baseline risk and treatment decisions in non-ST elevation acute coronary syndromes: an examination of international practice patterns (2005) (20)
Predicting appropriate shocks in patients with heart failure: Patient level meta‐analysis from SCD‐HeFT and MADIT II (2016) (20)
Safety of coronary CT angiography and functional testing for stable chest pain in the PROMISE trial: A randomized comparison of test complications, incidental findings, and radiation dose. (2017) (20)
Economic and Quality-of-Life Outcomes of Natriuretic Peptide-Guided Therapy for Heart Failure. (2018) (19)
Economic Analysis of Apixaban Therapy for Patients With Atrial Fibrillation From a US Perspective: Results From the ARISTOTLE Randomized Clinical Trial (2017) (19)
Fundamentals of economic analysis (1999) (19)
Use of the 6-min walk distance to identify variations in treatment benefits from implantable cardioverter-defibrillator and amiodarone: results from the SCD-HeFT (Sudden Cardiac Death in Heart Failure Trial). (2014) (18)
Ablation Versus Drug Therapy for Atrial Fibrillation in Racial and Ethnic Minorities. (2021) (18)
Surrogate assessment of coronary artery disease patients' functional capacity. (1997) (18)
Clinical correlates and prognostic significance of type A behavior and silent myocardial ischemia on the treadmill. (1989) (18)
Revascularization in stable coronary disease: evidence and uncertainties (2018) (17)
The effect of EDTA-based chelation on patients with diabetes and peripheral artery disease in the Trial to Assess Chelation Therapy (TACT). (2019) (17)
Prognostic value of predischarge electrocardiographic measurement of infarct size after thrombolysis: insights from GUSTO I Economics and Quality of Life substudy. (2004) (17)
Strategies for incorporating resource allocation and economic considerations: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). (2008) (17)
Economic analysis of the Assessment of the Safety and Efficacy of a New Thrombolytic Regimen (ASSENT-3) study: costs of reperfusion strategies in acute myocardial infarction. (2005) (17)
Improving the Use of Primary Prevention Implantable Cardioverter-Defibrillators Therapy With Validated Patient-Centric Risk Estimates. (2018) (16)
Preventing tomorrow's sudden cardiac death today: part II: Translating sudden cardiac death risk assessment strategies into practice and policy. (2007) (16)
Survival benefit of primary prevention implantable cardioverter-defibrillator therapy after myocardial infarction: does time to implant matter? A meta-analysis using patient-level data from 4 clinical trials. (2013) (16)
Palliative care and hospital readmissions in patients with advanced heart failure: Insights from the PAL‐HF trial (2016) (16)
Cosmetics, Regulations, and the Public Health: Understanding the Safety of Medical and Other Products. (2017) (16)
Using observational data to estimate prognosis: an example using a coronary artery disease registry (2001) (16)
Basic Doppler Echocardiography (1985) (15)
Sex differences in management and outcomes of patients with stable symptoms suggestive of coronary artery disease: Insights from the PROMISE trial (2016) (15)
Patient-Reported Outcomes in Atrial Fibrillation Research: Results of a Clinicaltrials.gov Analysis. (2019) (15)
Practice Guidelines (8th Edition) of Chest Physicians Evidence-Based Clinical Coronary Artery Disease: American College The Primary and Secondary Prevention of (2008) (15)
Long‐term outcomes of mitral regurgitation by type and severity (2018) (15)
Assessing the Economic Attractiveness of Coronary Artery Revascularization in Chronic Kidney Disease Patients (2009) (14)
Exploring options for improving healthcare. (2004) (14)
Atrial Fibrillation Burden and Heart Failure: Data from 39,710 Individuals with Cardiac Implanted Electronic Devices. (2021) (14)
Evaluating the Potential ‘Economic Attractiveness’ of New Therapies in Patients with Non-ST Elevation Acute Coronary Syndrome (2000) (14)
Long-Term Mortality of Patients With Acute Myocardial Infarction in the United States and Canada (2004) (14)
The progression of congestive heart failure over the course of the sudden cardiac death in heart failure trial (SCD-HeFT) (2005) (14)
Predictors of outcome and the lack of effect of percutaneous coronary intervention across the risk strata in patients with persistent total occlusion after myocardial infarction: Results from the OAT (Occluded Artery Trial) study. (2008) (13)
Impact of on-site cardiac interventional facilities on management and outcome of patients with acute coronary syndromes. (2003) (13)
Economic Outcomes With Anatomical Versus Functional Diagnostic Testing for Coronary Artery Disease. (2016) (12)
Rationale and design of the Home Automatic External Defibrillator Trial (HAT). (2008) (12)
Vasopeptidase inhibitor reduces inhospital costs for patients with congestive heart failure: results from the IMPRESS trial. Inhibition of Metallo Protease by BMS-186716 in a Randomized Exercise and Symptoms Study in Subjects With Heart Failure. (2002) (12)
Implications of Abnormal Exercise Electrocardiography With Normal Stress Echocardiography. (2020) (12)
709-1 Coronary Angioplasty in 20,006 Patients Over Age 80 in the United States (1995) (12)
Cost-Effectiveness of Extended Electrocardiogram Monitoring for Atrial Fibrillation After Stroke (2020) (12)
Careers for Clinician Investigators (2009) (12)
Disparities in Cardiovascular Research Output and Disease Outcomes among High-, Middle- and Low-Income Countries – An Analysis of Global Cardiovascular Publications over the Last Decade (2008–2017) (2021) (12)
Percutaneous intervention, surgery, and medical therapy: a perspective from the Duke Databank for Cardiovascular Diseases. (1994) (11)
Documents American College of Cardiology Foundation Task Force on Expert Consensus the Document on Coronary Computed Tomographic Angiography: A Report of ACCF/ACR/AHA/NASCI/SAIP/SCAI/SCCT 2010 Expert Consensus (2010) (11)
Ranolazine After Incomplete Percutaneous Coronary Revascularization in Patients With Versus Without Diabetes Mellitus: RIVER-PCI Trial. (2017) (11)
PCSK9 Inhibitors and the Choice Between Innovation, Efficiency, and Affordability. (2017) (11)
What is the economic value of digoxin therapy in congestive heart failure patients? Results from the DIG trial. (2006) (11)
Response to letters regarding article, "role of microvolt t-wave alternans in assessment of arrhythmia vulnerability among patients with heart failure and systolic dysfunction (2009) (10)
Pain Coping Strategies in Patients Referred for Evaluation of Angina Pectoris (1994) (10)
African Americans With Advanced Heart Failure Are More Likely to Die in a Health Care Facility Than at Home or in Hospice: An Analysis From the PAL-HF Trial. (2019) (10)
Using observational data to estimate prognosis: an example using a coronary artery disease registry. (2001) (10)
AB19-5: Mortality after appropriate and inappropriate shocks in SCD-HeFT (2006) (10)
Randomized trials of coronary artery bypass surgery: impact on clinical practice at Duke University Medical Center. (1985) (10)
Drone-Based Automatic External Defibrillators for Sudden Death?: Do We Need More Courage or More Serenity? (2017) (10)
Correlations Between Preprocedure Mood and Clinical Outcome in Patients Undergoing Coronary Angioplasty (2003) (10)
APIXABAN REDUCES HOSPITALIZATION IN PATIENTS WITH ATRIAL FIBRILLATION: AN ANALYSIS OF THE EFFECT OF APIXABAN THERAPY ON RESOURCE USE IN THE APIXABAN FOR REDUCTION IN STROKE AND OTHER THROMBOEMBOLIC EVENTS IN ATRIAL FIBRILLATION TRIAL (2013) (10)
Temporal evolution in the management of acute ST elevation myocardial infarction: the seven-year GUSTO experience from canada and the united states. The North American GUSTO-I and GUSTO-III investigators. (2000) (9)
How Reliable are Patient‐Reported Rehospitalizations? Implications for the Design of Future Practical Clinical Studies (2016) (9)
Cost-Effectiveness of Catheter Ablation Versus Antiarrhythmic Drug Therapy in Atrial Fibrillation: The CABANA Randomized Clinical Trial (2022) (9)
What we publish in the American Heart Journal and why (2007) (9)
Intracranial hemorrhage after thrombolytic therapy for acute myocardial infarction: Clinical characteristics and in-hospital outcome (1990) (9)
Use of resources, quality of life, and clinical outcomes in patients with and without new Q waves after thrombolytic therapy for acute myocardial infarction (from the GUSTO-I trial). (2000) (9)
Angina, myocardial ischemia and coronary disease: gold standards, operational definitions and correlations. (1989) (9)
Quality-of-Life Outcomes With a Disodium EDTA Chelation Regimen for Coronary Disease: Results From the Trial to Assess Chelation Therapy Randomized Trial (2014) (9)
An overview of risk assessment in coronary artery disease. (1994) (9)
Discordances between predicted and actual risk in obese patients with suspected cardiac ischaemia (2019) (9)
Early post-discharge bleeding and antiplatelet therapy discontinuation among acute myocardial infarction patients treated with percutaneous coronary intervention. (2014) (9)
Intracoronary brachytherapy: time to sell short? (2002) (8)
Economic and cost-effectiveness in evaluating the value of cardiovascular therapies. The impact of the cost-effectiveness study of GUSTO-1 on decision making with regard to fibrinolytic therapy. (1999) (8)
Health Economics in the PLATelet Inhibition and Patient Outcomes (PLATO) Randomized Trial: Report on Within Trial Resource Use Patterns (2010) (8)
Cardiovascular Health: A Challenge for Midlife (1999) (8)
Impact of Ezetimibe on the Rate of Cardiovascular-Related Hospitalizations and Associated Costs Among Patients With a Recent Acute Coronary Syndrome: Results From the IMPROVE-IT Trial (Improved Reduction of Outcomes Vytorin Efficacy International Trial) (2017) (8)
Intracranial hemorrhage risk and new thrombolytic therapies in acute myocardial infarction. (1994) (8)
When innovative therapies make economic sense: economic analysis of enoxaparin versus unfractionated heparin in the ESSENCE trial--an overview. Efficacy and Safety of Subcutaneous in non-Q Wave Coronary Events. (1998) (8)
DISCORDANCES BETWEEN PREDICTED AND ACTUAL RISK OF ADVERSE EVENTS IN OBESE PATIENTS WITH SUSPECTED CARDIAC ISCHEMIA: INSIGHTS FROM THE PROMISE TRIAL (PROSPECTIVE MULTICENTER IMAGING STUDY FOR EVALUATION OF CHEST PAIN) (2017) (8)
DISCORDANCES BETWEEN PREDICTED AND ACTUAL RISK OF ADVERSE EVENTS IN OBESE PATIENTS WITH SUSPECTED CARDIAC ISCHEMIA: INSIGHTS FROM THE PROMISE TRIAL (PROSPECTIVE MULTICENTER IMAGING STUDY FOR EVALUATION OF CHEST PAIN) (2017) (8)
CAN WE? (2018) (8)
Fixing the heart: must the brain pay the price? (2004) (8)
Risk stratification in patients with chest pain. (2001) (8)
Interventional Cardiology Long-Term Effects of Percutaneous Coronary Intervention of the Totally Occluded Infarct-Related Artery in the Subacute Phase After Myocardial Infarction (2011) (8)
Noninvasive imaging for coronary artery disease: a technology assessment for the Medicare Coverage Advisory Commission. (2007) (7)
Re-evaluating the volume-outcome relationship in hemodialysis patients. (2008) (7)
Effects of initial invasive vs. initial conservative treatment strategies on recurrent and total cardiovascular events in the ISCHEMIA trial. (2021) (7)
Survival After Invasive or Conservative Management of Stable Coronary Disease (2022) (7)
Development and validation of a simple model to predict severe coronary artery disease after myocardial infarction: potential impact on cardiac catheterization use in the United States and Canada. (2003) (7)
Cost-Effectiveness of New Diagnostic Tools and Therapies for Acute Coronary Syndromes (2004) (7)
Diagnosis-to-ablation time predicts recurrent atrial fibrillation and rehospitalization following catheter ablation (2021) (7)
Early hospital discharge after uncomplicated myocardial infarction: are further improvements possible? (2003) (7)
Quality of life effects of automatic external defibrillators in the home: results from the Home Automatic External Defibrillator Trial (HAT). (2010) (7)
Economic end points in phase II trials. (2000) (7)
Neurocognitive dysfunction and quality of life after cardiac surgery (2000) (7)
Downstream testing and subsequent procedures after coronary computed tomographic angiography following coronary stenting in patients ≥65 years of age. (2012) (7)
Impact of different patterns of invasive care on quality of life outcomes in patients with non-ST elevation acute coronary syndrome: results from the GUSTO-IIb Canada-United States substudy. (2004) (7)
Cost estimates for treatment of cardiac ischemia (from the Asymptomatic Cardiac Ischemia Pilot [ACIP] study). (1999) (6)
Depression as risk factor for mortality after coronary artery bypass surgery (2003) (6)
Economic Evaluation of Catheter Ablation of Atrial Fibrillation in Patients with Heart Failure With Reduced Ejection Fraction (2020) (6)
Conservative management of acute coronary syndrome: cheaper and better for you? (2002) (6)
Relationship of female sex to outcomes after myocardial infarction with persistent total occlusion of the infarct artery: analysis of the Occluded Artery Trial (OAT). (2012) (6)
Treatment-Related Changes in Left Atrial Structure in Atrial Fibrillation (2021) (6)
Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitor Therapy-Breakthrough in Low-Density Lipoprotein Cholesterol Lowering, Breakdown in Value. (2017) (6)
ISCHEMIA trial update. (2019) (6)
Importance of cost and quality of life in decisions about routine angiography after acute myocardial infarction. The role of cost-effectiveness models. (1996) (6)
The Placement of Aortic Transcatheter Valve (PARTNER) trial: a health economic and policy perspective. (2012) (6)
Do patients with a left ventricular ejection fraction between 30% and 35% benefit from a primary prevention implantable cardioverter defibrillator? (2014) (6)
Abstract 2428: Patients Who Receive an Implantable Cardioverter Defibrillator for MADIT-II Criteria in Clinical Practice are Different From Patients Enrolled in MADIT-II (2007) (6)
3 : Decision-Making in Clinical Medicine (2017) (5)
Non-Invasive Imaging for Coronary Artery Disease (2006) (5)
Health-related quality of life outcomes with prasugrel among medically managed non-ST-segment elevation acute coronary syndrome patients: Insights from the Targeted Platelet Inhibition to Clarify the Optimal Strategy to Medically Manage Acute Coronary Syndromes (TRILOGY ACS) trial. (2016) (5)
Glycoprotein IIb-IIIa inhibition with abciximab and postprocedural risk assessment: lessons from the evaluation of platelet IIb/IIIa inhibitor for stenting trial and implication for ad hoc use of glycoprotein IIb-IIIa antagonists. (2002) (5)
Impact of Diabetes Mellitus on the Evaluation of Stable Chest Pain Patients: Insights From the PROMISE (Prospective Multicenter Imaging Study for Evaluation of Chest Pain) Trial (2017) (5)
FOCUS ISSUE: CARDIAC RESYNCHRONIZATION THERAPY STATE-OF-THE-ART PAPERS Cardiac Resynchronization Therapy (2005) (5)
Cardiac computed tomographic angiography what's the prognosis? (2010) (5)
Expert Consensus Document Accf/acr/aha/nasci/saip/scai/scct 2010 Expert Consensus Document on Coronary Computed Tomographic Angiography a Report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents Writing Committee Members Expert Consensus Document Table of Cont (5)
Abstract 1872: Beta Blocker (BB) Use Was Associated with Reduced Atrial Fibrillation (AF) and Flutter (AFL) in the Sudden Cardiac Death Heart Failure Trial (SCD-HeFT) (2006) (5)
Comprehensive Quality-of-Life Outcomes With Invasive Versus Conservative Management of Chronic Coronary Disease in ISCHEMIA (2022) (5)
Assessing the value of newer pharmacologic agents in non-ST elevation patients: a decision support system application (1997) (5)
Clinical and economic lessons from studies of coronary thrombolysis. (1995) (4)
Issues of cost-effectiveness in the use of antithrombotic therapy for ischemic heart disease. (1997) (4)
Effect of Type A behavior on exercise test outcome in coronary artery disease. (1990) (4)
Economics and cost-effectiveness in evaluating the value of cardiovascular therapies. Use of abciximab: comparative economic data. (1999) (4)
Navigating the scylla and charybdis of chest pain management in the emergency department. Is a computer the answer? (2002) (4)
Quantifying sociodemographic and income disparities in medical therapy and lifestyle among symptomatic patients with suspected coronary artery disease: a cross-sectional study in North America (2017) (4)
BYSTANDER PERFORMANCE DURING SIMULATED DRONE DELIVERY OF AN AED FOR MOCK OUT-OF-HOSPITAL CARDIAC ARREST (2020) (4)
Initial Thoracic Endovascular Aortic Repair vs Medical Therapy for Acute Uncomplicated Type B Aortic Dissection. (2022) (4)
Effects of obesity on noninvasive test results in patients with suspected cardiac ischemia: Insights from the PROMISE trial. (2019) (4)
Pheochromocytoma presenting as fever of unknown origin. (2011) (4)
Aggressive therapy of acute myocardial infarction in the elderly (1990) (4)
Quality still doesn't pay in heart failure management. (2003) (4)
Economics of Glycoprotein IIb/IIIa Inhibition (1999) (4)
Health Economics of Acute Coronary Syndromes (1998) (4)
Chelation therapy and cardiovascular outcomes--in reply. (2013) (4)
SURVIVAL BENEFIT OF THE PRIMARY PREVENTION IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR AMONG OLDER PATIENTS: DOES AGE MATTER? A PATIENT-LEVEL META-ANALYSIS OF 5 CLINICAL TRIALS (2014) (4)
AB19-1: Decreased impact of implantable defibrillators on sudden cardiac death in patients with renal insufficiency and heart failure: An analysis of the SCD-HeFT (2006) (4)
The Prospective Randomized Trial of the Optimal Evaluation of Cardiac Symptoms and Revascularization: Rationale and Design of the PRECISE Trial (2021) (4)
Cost avoidance through early discharge of the uncomplicated acute myocardial infarction patient (1996) (3)
The Trial to Assess Chelation Therapy 2 (TACT2): Rationale and Design. (2022) (3)
Abstract 2811: Predictors of Outcome and the Lack of Effect of PCI Across the Risk Strata in Patients With Persistent Total Occlusion After Myocardial Infarction: Results from the Occluded Artery Trial (OAT) (2007) (3)
Interpreting the music of drug-eluting stents: halcyon song or albatross dirge? (2008) (3)
SCD-HEFT: NON-SUSTAINED VENTRICULAR TACHYCARDIA ON BASELINE HOLTER MONITOR ASSOCIATION WITH APPROPRIATE IMPLANTABLE CARDIOVERTER DEFIBRILLATOR THERAPY FOR VENTRICULAR TACHYCARDIA AND VENTRICULAR FIBRILLATION (2011) (3)
PCV59 ECONOMIC ANALYSIS OF THE ENDEAVOR DRUG-ELUTING STENT VS. THE DRIVER BARE METAL STENT: RESULTS FROM THE ENDEAVOR II TRIAL (2009) (3)
RESEARCH PARTICIPATION AS A PREDICTOR OF SURVIVAL IN CARDIAC PATIENTS: POSSIBLE MECHANISMS (1998) (3)
Six-minute walk distance after coronary artery bypass grafting compared with medical therapy in ischaemic cardiomyopathy (2018) (3)
Mortality following acute myocardial infarction according to physician experience, technical training, and specialty (1998) (3)
Coronary Catherization Patient and Wife's Perceptions of Social Support: Effects Due to Characteristics of Recipient, Provider, and Their Interaction (2000) (3)
Early discharge following coronary artery bypass surgery does not increase readmission rates or death (1996) (3)
Economics and cost-effectiveness in evaluating the value of cardiovascular therapies. Fundamentals of economic analysis. (1999) (3)
Economic burden of nonischemic congestive heart failure: Evidence from PRAISE-2 (2003) (3)
Design Considerations for UAV-Delivered Opioid Overdose Interventions (2019) (3)
Long-term costs of therapy for CAD A prospective comparison of coronary angioplasty, coronary bypass surgery and medical therapy in 2258 patients (1993) (3)
Effect of high‐dose oral multivitamins and minerals in participants not treated with statins in the randomized Trial to Assess Chelation Therapy (TACT) (2018) (3)
Abstract 18053: Prognostic Value of Anatomic versus Functional Diagnostic Testing in Symptomatic Patients With Suspected CAD: The PROMISE Trial (PROspective Multicenter Imaging Study for Evaluation of Chest Pain) (2015) (3)
Relationship Between Optimism and Outcomes in Patients With Chronic Angina Pectoris. (2019) (3)
Assessing Quality of Life and Medical Care in Chronic Angina: An Internet Survey (2016) (3)
Introduction of a new section: Cardiology Fellows: Quick Evidence-Based Consult (2004) (3)
Loss of short-term symptomatic benefit in patients with an occluded infarct artery is unrelated to non-protocol revascularization: results from the Occluded Artery Trial (OAT). (2011) (3)
Clinical characteristics andlong-term survival of patients withvariant angina (1984) (2)
CORONARY ANATOMY, ISCHEMIA AND ANGINA: ASSOCIATIONS AT BASELINE IN THE ISCHEMIA TRIAL (2020) (2)
Surgeons’ Economic Profiles: Can We Get the “Right” Answers? (2005) (2)
Possible differential benefits of edetate disodium in post-myocardial infarction patients with diabetes treated with different hypoglycemic strategies in the Trial to Assess Chelation Therapy (TACT). (2020) (2)
EXERCISE CAPACITY AND MORTALITY IN PATIENTS WITH ISCHEMIC LEFT VENTRICULAR DYSFUNCTION RANDOMIZED TO CORONARY ARTERY BYPASS SURGERY OR MEDICAL THERAPY: AN ANALYSIS FROM THE SURGICAL TREATMENT FOR ISCHEMIC HEART FAILURE TRIAL (2014) (2)
Physician judgement in predicting obstructive coronary artery disease and adverse events in chest pain patients (2022) (2)
SEX DIFFERENCES IN DEMOGRAPHICS, RISK FACTORS AND PRESENTATION IN STABLE CONTEMPORARY OUTPATIENTS WITH SUSPECTED CORONARY ARTERY DISEASE: INSIGHTS FROM THE PROMISE TRIAL (2016) (2)
Abstract 16776: Can We Rely on Patients to Report Rehospitalizations After Acute Myocardial Infarction? Implications for the Design of Future Practical Clinical Studies (2014) (2)
Sex Differences in Functional Stress Test Versus CT Angiography in Symptomatic Patients With Suspected CAD : Insights From PROMISE (2016) (2)
Economic Outcomes With Anatomical Versus Functional Diagnostic Testing for Coronary Artery Disease (2016) (2)
TPRD7: ESTIMATING LIFE-EXPECTANCY IN POSTACUTE CORONARY SYNDROMES: THE IMPORTANCE OF TWO-COMPONENT SURVIVAL MODELS (1999) (2)
Trade-offs and toss-ups: making revascularization decisions in carotid artery disease. (2011) (2)
Economics and quality of life after acute myocardial infarction: Insights from GUSTO-I (2004) (2)
Identification of Patients With Coronary Disease (2005) (2)
Patterns of Change in Quality of Life with a Palliative Care Intervention for Patients with Advanced Heart Failure: Insights from PAL-HF (2019) (2)
A comparison of clinical events in a randomized clinical trial of DDDR versus DDD pacing (2005) (2)
Association of Medication Adherence With Health Outcomes in the ISCHEMIA Trial. (2022) (2)
Noninvasive testing is done only in low risk patients with unstable angina and non-Q-wave Myocardial Infarction (MI): Results from GUSTO-IIa (1996) (2)
Abstract 3625: Do Patients Who Meet SCD-HeFT Criteria in Clinical Practice Differ from Patients Enrolled in SCD-HeFT? (2007) (2)
Polypharmacy in Palliative Care for Advanced Heart Failure: The PAL-HF Experience. (2021) (2)
OUTCOMES IN PATIENTS WITH DIABETES MELLITUS AND SUSPECTED CORONARY ARTERY DISEASE FOLLOWING NON-INVASIVE TESTING: INSIGHTS FROM THE PROMISE TRIAL (PROSPECTIVE MULTICENTER IMAGING STUDY FOR EVALUATION OF CHEST PAIN) (2017) (2)
Costs of interventional cardiac procedures. (1994) (2)
When Business and Science Clash, How Can We Avoid Harming Patients?: The Case of AVOID-HF. (2016) (2)
Abstract 16741: The Cost-Effectiveness of Apixaban versus Warfarin in Patients With Atrial Fibrillation: Insights From the ARISTOTLE Study Group (2014) (2)
Effect of Natriuretic Peptide-Guided Therapy on Outcomes in High-Risk Patients with Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial (2017) (2)
SOCIAL SUPPORT AND HOSTILITY PREDICT DEPRESSION 1 MONTH FOLLOWING DIAGNOSTIC ANGIOGRAPHY (1998) (2)
SCD-HEFT: NON-SUSTAINED VENTRICULAR TACHYCARDIA ON BASELINE HOLTER MONITOR ASSOCIATION WITH OVERALL MORTALITY (2011) (2)
Dapagliflozin-Does Cost Make 4-Pillar Heart Failure Therapy Too Herculean a Labor for Medicine? (2021) (2)
Potential for cost savings in high cost coronary bypass surgery patients: A New York State analysis (1996) (2)
Long Term Results from the Global Utilization of Streptokinase and tPA for Occluded Coronary Arteries (GUSTO-I) Trial: Sustained Benefit of Fibrin-Specific Therapy (1999) (2)
DIFFERENTIAL OUTCOMES WITH CHELATION THERAPY AMONG PATIENTS WITH ANTERIOR VERSUS NON-ANTERIOR MYOCARDIAL INFARCTION: A TACT SUBSTUDY (2014) (2)
901-84 Prognostic Value of Right Heart Catheterization Hemodynamic Data in Surgically Treated Patients with Coronary Artery Disease (1995) (2)
Catheter Ablation Compared With Drug Therapy for Atrial Fibrillation-Reply. (2019) (2)
Reply: rapid rate nonsustained ventricular tachycardia found on ICD interrogation: relationship of RR-NSVT to outcomes in the SCD-HeFT trial. (2013) (2)
B-PO05-069 SEX-SPECIFIC QUALITY OF LIFE OUTCOMES OF ABLATION VERSUS DRUG THERAPY FOR AF: INSIGHTS FROM CABANA (2021) (1)
Analysis of risk factors for sudden death after acute myocardial infarction. (1985) (1)
Race Differences in Quality of Life following a Palliative Care Intervention in Patients with Advanced Heart Failure: Insights from the Palliative Care in Heart Failure Trial. (2021) (1)
Quality improvement and clinical research: an important partnership. (1997) (1)
Differences in Cardiovascular Risk, Coronary Artery Disease, and Cardiac Events Between Black and White Individuals Enrolled in the PROMISE Trial (2021) (1)
Patient-Reported Outcome Measures in Cardiovascular Disease: An Evidence Map of the Psychometric Properties of Health Status Instruments (2022) (1)
Abstract 11054: Clinical Benefit of EDTA-based Chelation Therapy and High-dose Oral Multivitamins and Multiminerals in TACT- An Expanded Comparison of 2 Factorial Groups (2013) (1)
Association between Economic and Arrhythmic Burden of Paroxysmal Atrial Fibrillation in Patients with Cardiac Implanted Electronic Devices. (2021) (1)
Abstract 13116: Persistent Lack of Benefit of Late Revascularization of the Occluded Coronary Artery Post-MI - The Occluded Artery Trial (OAT) Long Term Results (2010) (1)
Percutaneous coronary revascularisation: is it ever worth what it costs? (2007) (1)
Economics of Therapy for Acute Coronary Syndromes (2003) (1)
Outcomes for Patients with Anterior Myocardial Infarction and Prior Cardiac Arrest in the Home Automated External Defibrillator Trial (HAT). (2021) (1)
Differential outcomes with edetate disodium-based treatment among stable post anterior vs. non-anterior myocardial infarction patients. (2020) (1)
Regional variations in treatment costs and resource utilization for uncomplicated acute myocardial infarction (UMI) (1996) (1)
Economic impact of new interventional therapies: are we asking the right questions? (2004) (1)
Abstract 14051: Changes in Medical Therapy and Lifestyle After Anatomical Versus Functional Testing for Coronary Artery Disease: The PROMISE Trial (PROspective Multicenter Imaging Study for Evaluation of Chest Pain) (2015) (1)
Presenting Symptoms in Patients Undergoing Coronary Artery Disease Evaluation: Association With Noninvasive Test Results and Clinical Outcomes in the PROMISE Trial (2022) (1)
Abstract 11546: Clinical Benefit of EDTA Chelation Therapy in Patients With Diabetes in the Trial to Assess Chelation Therapy (TACT) (2013) (1)
Clinical and Economic Implications of Inconclusive Noninvasive Test Results in Stable Patients With Suspected Coronary Artery Disease (2020) (1)
Abstract 10476: Effect of High-dose Oral Multi-vitamins and Minerals in Patients Not Treated With Statins in the Trial to Assess Chelation Therapy (2015) (1)
Health Status and Clinical Outcomes in Older Adults With Chronic Coronary Disease: The ISCHEMIA Trial. (2023) (1)
Abstract 151: Barriers and Opportunities for a Drone-Delivered AED Network in Durham, North Carolina (2020) (1)
Does an educational intervention influence patient decision making? Impact of an interactive video on ischemic heart disease patients (2002) (1)
Abstract 13035: Impact of Ezetimibe on Hospitalization-Related Costs Among Patients With a Recent Acute Coronary Syndrome: Results From the IMPROVE-IT Trial (2015) (1)
Coapting Cost and Clinical Outcomes in Transcatheter Intervention for Secondary Mitral Regurgitation. (2019) (1)
Arrhythmic Burden and the Risk of Cardiovascular Outcomes in Patients With Paroxysmal Atrial Fibrillation and Cardiac Implanted Electronic Devices. (2022) (1)
Leveling the playing field in outcomes comparisons: Patient versus medical record data (1996) (1)
Influence of poverty on process of care and outcome in acute coronary syndromes (2002) (1)
Our vision for the American Heart Journal. (1997) (1)
Surgical Treatment of Ischemic Heart Failure Trial (2011) (1)
Abstract 10466: Post-myocardial Infarction Treatment With Edetate Disodium was Safe in the Trial to Assess Chelation Therapy (2015) (1)
Abstract 18819: Graded Benefit of EDTA Chelation in Post-MI Patients with Diabetes Treated with Different Hypoglycemic Strategies (2014) (1)
Factors and outcomes associated with improved left ventricular systolic function in patients with cardiomyopathy (2020) (1)
Reply: circadian variations of ventricular arrhythmias and sleep-disordered breathing in HF patients. (2014) (1)
PHYSICIAN JUDGMENT MORE ACCURATE THAN DIAMOND-FORRESTER RISK SCORE IN PREDICTING OBSTRUCTIVE CAD AND ADVERSE CARDIAC EVENTS IN PATIENTS WITH CHEST PAIN: INSIGHTS FROM THE PROMISE TRIAL (2018) (1)
Cost Effectiveness of Prevention of Cardiovascular Disease (2007) (1)
Clinical Cardiology, and Council on Cardiovascular Disease in the Young on behalf of the American Heart Association Council on Cardiovascular Nursing, Council on (2013) (0)
Clinical and Cost Implications of Deferred Testing in Low-risk Patients with Stable Chest Pain: A Simulation Using the PROMISE Trial. (2023) (0)
Effects of Ablation Versus Drug Therapy on Quality of Life by Sex in Atrial Fibrillation: Results From the CABANA Trial (2023) (0)
Pain Coping Strategies in Patients Referred for Evaluation of Angina Petients Referred for Evaluation of Angina Pectoris (1994) (0)
RACIAL DIFFERENCES IN INTEGRATED FIRST RESPONDER AND DRONE AUTOMATED EXTERNAL DEFIBRILLATOR DELIVERY IN NORTH CAROLINA (2023) (0)
B-PO02-086 METHODS AND OUTCOMES FOR ABLATION IN THE CABANA TRIAL (2021) (0)
Influence of atrial fibrillation type on outcomes of ablation vs. drug therapy: results from CABANA. (2022) (0)
P2832Outcomes of catheter ablation for atrial fibrillation based on sex: data from the cabana trial (2019) (0)
Geographical region differences in the Cabana trials (2020) (0)
Abstract 14262: Atrial Fibrillation Burden and Clinical Outcomes in Patients With Cardiac Implanted Electronic Devices (2020) (0)
Cost-Effectiveness of Coronary Artery Bypass Surgery Versus Medicine in Ischemic Cardiomyopathy: The STICH Randomized Clinical Trial (2022) (0)
Clinical significance of chronotropic incompetence in 872 ADEPT patients (2005) (0)
Abstract 231: Single Bystander CPR Performance During Drone AED Delivery for Simulated Out of Hospital Cardiac Arrest (2020) (0)
CABANA: underpowered and with detrimental protocol changes: is 'ablation salvation'?-Reply by the authors of the CABANA trial. (2021) (0)
Cost-Effectiveness of Follow-Up of Pulmonary Nodules Incidentally Detected on Cardiac CT Angiography in Patients with Suspected Coronary Artery Disease (2014) (0)
Opportunities and challenges to non-communicable disease (NCD) research and training in Pakistan: a qualitative study from Pakistan (2022) (0)
Predictors of quality of life in 872 paced patients with chronotropic incompetence in the ADEPT study (2005) (0)
B-PO04-202 ASSOCIATIONS BETWEEN ATRIAL FIBRILLATION ARRHYTHMIC BURDEN AND MEDICARE COSTS (2021) (0)
Post-discharge Bleeding and Thienopyridine Discontinuation among AMI Patients Treated with PCI: Insights from the TRANSLATE-ACS Study (2011) (0)
RELATIONSHIP OF HEALTH STATUS TO ISCHEMIA AND CORONARY ANATOMY IN THE ISCHEMIA TRIAL (2022) (0)
Prognostic/Clinical Prediction Models: Using Observational Data to Estimate Prognosis: An Example Using a Coronary Artery Disease Registry (2005) (0)
Abstract 2482: Quantification of Myocardial Scar Using a Simple ECG Tool Identifies Patients at Risk for Sudden Arrhythmic Death: An Analysis of SCD-HeFT (2009) (0)
Abstract 10329: Health Status Outcomes of Percutaneous Coronary Intervention and Coronary Artery Bypass Grating in Stable Coronary Disease: Secondary Analysis of the ISCHEMIA Trial (2021) (0)
Quality of Life and Cost-Effectiveness Associated with the Late Opening of a Total Occluded Artery (2007) (0)
P2-69: Septadian variation in life-threatening ventricular arrhythmias in SCD-HeFT (2006) (0)
Identifying Quality of Life Outcome Patterns to Inform Treatment Choices in Ischemic Cardiomyopathy. (2022) (0)
Abstract 17: Association Between Age And Health Status In Chronic Coronary Disease With An Initial Invasive Or Conservative Strategy: Insights From The ISCHEMIA Trial (2022) (0)
Cost and quality of life outcomes in the TAMI 5 trial: The primacy of secondary endpoints (1990) (0)
Abstract 18783: Predictive Model for High-Risk Coronary Artery Disease: An Analysis From PROMISE (2016) (0)
CV3: VASOPEPTIDASE INHIBITOR REDUCES IN-HOSPITAL COSTS FOR CONGESTIVE HEART FAILURE PATIENTS: RESULTS FROM THE IMPRESS TRIAL (2001) (0)
Prognostic ValueofRadionuclide Angiography inMedically Treated Patients WithCoronary Artery Disease A Comparison WithClinical andCatheterization Variables (1990) (0)
Noninvasive FFR Derived From CoronaryCT Angiography (2017) (0)
Home health care for coronary artery disease patients impacts quality of life (2003) (0)
Research, Managed Care, and Patient Privacy: Challenges to Successful Collaboration (2005) (0)
AN AGE- AND SEX-SPECIFIC PERIPHERAL BLOOD GENE EXPRESSION SCORE CORRELATES WITH FUTURE CARDIOVASCULAR EVENTS: INSIGHTS FROM THE PROMISE TRIAL (2016) (0)
Making Revascularization Decisions in Carotid Artery Disease (2011) (0)
Effect of gender on angioplasty outcome: are we closer to the answer? (1997) (0)
Response to Letter Regarding Article, “Impact of Implantable Cardioverter-Defibrillator, Amiodarone, and Placebo on the Mode of Death in Stable Patients With Heart Failure: Analysis From the Sudden Cardiac Death in Heart Failure Trial” (2010) (0)
Angioplasty for Acute Myocardial Infarction (2005) (0)
Patient-Reported Outcomes in Revascularization Decisions for Left-Main Disease: Sharing the EXCELlence. (2017) (0)
PATTERNS OF PREVENTIVE MEDICAL THERAPY AND LIFESTYLE PRACTICES IN PATIENTS EVALUATED FOR SUSPECTED CORONARY ARTERY DISEASE: THE PROMISE TRIAL (PROSPECTIVE MULTICENTER IMAGING STUDY FOR EVALUATION OF CHEST PAIN) (2016) (0)
Socioeconomic status and medical care use in coronary disease patients (1998) (0)
PCD2: ASSESSING THE BURDEN OF ILLNESS IN ELDERLY VERSUS YOUNGER ACUTE CORONARY SYNDROME PATIENTS (2000) (0)
Ischemic Heart Disease Resource Use and Cost of Initial Coronary Revascularization (2005) (0)
Inverse correlation between increasing local rates of coronary artery bypass graft and the average anticipated survival benefit. (1997) (0)
EFFECT OF CHELATION THERAPY ON CARDIOVASCULAR EVENTS BY CHRONIC KIDNEY DISEASE STAGE: DATA FROM THE TRIAL TO ASSESS CHELATION THERAPY (TACT) (2014) (0)
Optimising outcomes: socioeconomic perspective (1999) (0)
The high cost of implantable defibrillators. Commentary (2007) (0)
CO-MORBIDITIES AND ETHNICITY/RACE PREDICT MORBIDITY AND MORTALITY IN HIGH RISK HEART FAILURE PATIENTS WITH SYSTOLIC DYSFUNCTION: THE GUIDE-IT PREDICTIVE RISK MODEL (2018) (0)
Using Death as an Endpoint (2017) (0)
Abstract 12202: New York Heart Association Class and the Mortality Benefit From Primary Prevention Implantable Cardioverter Defibrillator Use: A Pooled Analysis of 4 Randomized Control Trials (2016) (0)
RESPONSES Let ' s Not SPRINT to Judgment About New Blood Pressure Goals (2016) (0)
ICD Implantation and Evidence-Based Patient Selection—Reply (2011) (0)
The importance of physician procedural skills in management decisions for acute myocardial infarction (1998) (0)
Does the Metabolic Syndrome Add Prognostic Information Beyond Traditional Risk Factors in the Prediction of Sudden Cardiac Death? Insights from the Atherosclerosis in Communities (ARIC) Study (MS1875) (2011) (0)
Social and Economic Factors in Patients With Coronary Disease-Reply (1992) (0)
Higher procedure use in the United States versus Canada among non-ST elevation acute coronary syndrome patients not associated with better quality of life outcomes (2002) (0)
715-3 Cost Implications of Aortic Counterpulsation in Acute Myocardial Infarction: Results from a Randomized Clinical Trial (1995) (0)
Medico-Legal Principles of Emergency and Intensive Medical Care (1987) (0)
Medical Interventions in Unstable Angina: Does International Clinical Practice Match Evidence-Based Guidelines? (1997) (0)
Patient, hospital, physician, and market correlates of one-year costs after acute myocardial infarction in the elderly (2003) (0)
Patient-Reported Outcomes in Revascularization Decisions for Left-Main Disease (2017) (0)
P2-78: Circadian variation of ventricular arrhythmias in SCD-HeFT (2006) (0)
ASSENT-3 Economic Analysis: Costs of Reperfusion Strategies in Acute Myocardial Infarction (2002) (0)
SOCIAL AND ECONOMIC FACTORS IN PATIENTS WITH CORONARY DISEASE. AUTHORS' REPLY (1992) (0)
P31 Reliability of economic and quality of life data for collection of follow-up clinical outcome information (1996) (0)
Comparison of Quality-of-Life Measures after Radial versus Femoral Artery Access for Cardiac Catheterization in Women: Results of the SAFE-PCI for Women Quality-of-Life Substudy Short title: Hess et al.: QOL in SAFE-PCI for Women (2015) (0)
The MANTRA II study – Authors' reply (2005) (0)
Risk stratification in patients with chest pain. (1994) (0)
Abstract 16626: Age-related Differences in Presentation and Assessed Risk of Suspected Coronary Artery Disease in the Clinic: Insights From the PROMISE Trial (2016) (0)
IDENTIFYING STABLE CHEST PAIN PATIENTS WITH SUSPECTED CORONARY DISEASE IN WHOM NONINVASIVE TESTING MAY BE SAFELY DEFERRED: INSIGHTS FROM THE PROMISE TRIAL (PROSPECTIVE MULTICENTER IMAGING STUDY FOR EVALUATION OF CHEST PAIN) (2016) (0)
CM4 Use of UB-92S And Medicare Cost Reports in A Large, Multi-Center Randomized Trial: The Pursuit Experience (1998) (0)
Abstract 16630: Clinical Benefit of Chelation Therapy in Post-MI Patients With Diabetes and Peripheral Artery Disease (2014) (0)
WHAT IS THE VALUE OF REPEATED NT-PROBNP MEASUREMENTS IN CHRONIC HEART FAILURE WITH REDUCED EJECTION FRACTION? (2023) (0)
Long-term survival in blacks versus whites with Coronary Artery Disease (CAD) (1996) (0)
Has American Heart Journal gone to the blogs (2009) (0)
SCD-HEFT: TURBULENCE SLOPE AND FRACTAL INFORMATION FROM BASELINE HOLTER MONITORING MAY AVOID UNNECESSARY IMPLANTABLE CARDIOVERTER DEFIBRILLATOR THERAPY DESPITE HEART FAILURE (2013) (0)
Cost-Effectiveness of Left Atrial Appendage Occlusion: A Case Based on Facts Not in Evidence? (2016) (0)
Brief Introduction to Clinical Reasoning Clinical Expertise Defining (2017) (0)
Changing Efficacy of Coronary Revascularization (2005) (0)
INFLUENCE OF CHRONIC KIDNEY DISEASE ON THE EFFICACY OF PRIMARY PREVENTION IMPLANTABLE CARDIOVERTER DEFIBRILLATORS: A META-ANALYSIS OF THREE RANDOMIZED TRIALS (2013) (0)
Analysis of medical costs as a secondary end-point in a clinical trial (1991) (0)
Abstract 3768: Thyroid Function and Mortality in the Sudden Cardiac Death in Heart Failure Trial (2006) (0)
Abstract 10369: Safety of Anatomic versus Functional Diagnostic Testing: Insights From the PROMISE Trial (PROspective Multicenter Imaging Study for Evaluation of Chest Pain) (2015) (0)
The effect of public release of bypass surgery mortality data on procedural access in the elderly: New York State (1996) (0)
Lessons for the editors (1997) (0)
Use of the 6-Min Walk Distance to IdentifyVariations in Treatment Benefits FromImplantable Cardioverter-Defibrillator andAmiodarone (2014) (0)
Abstract 14364: External Validation of the CAD Consortium Prediction Models for the Presence of Coronary Artery Disease in Patients With Stable Chest Pain (2016) (0)
The Cost-Effectiveness of Palliative Care: Insights from the PAL-HF Trial. (2021) (0)
(8th Edition) Evidence-Based Clinical Practice Guidelines American College of Chest Physicians Allocation and Economic Considerations: Strategies for Incorporating Resource (2008) (0)
PROMISE: Anatomic and Functional CAD Testing Comparable in Clinical Outcome and Cost (2015) (0)
Abstract 089: Can Medical Claims Accurately Assess Cardiovascular and Bleeding Events in an All-Aged Post-Myocardial Infarction Population? Insights Fom the TRANSLATE-ACS Study (2017) (0)
Conservative Management of Acute Coronary Syndrome (2002) (0)
Abstract 18178: Cause-Specific Mortality in Patients with Prior Anterior Myocardial Infarction: Clinical Predictors Identified in the Home Automated External Defibrillator Trial (2010) (0)
Quality of Life after Coronary Revascularization in the United States and Canada: The Bypass Angioplasty Revascularization Investigation (BARI) (2000) (0)
Abstract 20846: The Impact of a Palliative Care Intervention on Polypharmacy in Advanced HF: Results From Pal-HF (2017) (0)
Abstract 2140: Infrequent Need for Pacing Following Implantable Cardioverter-Defibrillator Shocks: Analysis of the Sudden Cardiac Death in Heart Failure Trial (2008) (0)
791-2 Regional Variations in the Use of Cardiac Procedures After Thrombolysis: New England is an Outlier in the GUSTO Trial (1995) (0)
AB19-3: Failure of spironolactone to reduce mortality or the need for an ICD in chronic moderate heart failure: Observations from the sudden cardiac death heart failure trial (2006) (0)
MYOCARDIAL ISCHEMIA Value of Exercise Treadmill Testing in Women (2016) (0)
Dealing with success at the American Heart Journal (1999) (0)
Transitions at the American Heart Journal (2015) (0)
Cost implications for treatment of cardiac ischemia: An ancillary Asymptomatic Cardiac Ischemia Pilot (ACIP) study (1996) (0)
PERCEPTION OF COGNITIVE IMPAIRMENT IN OLDER ADULTS UNDERGOING CARDIAC SURGERY (1998) (0)
1153-74 Physician counseling can influence health-related quality of life (2004) (0)
Patterns of Change in Individual Domains of the Kansas City Cardiomyopathy Questionnaire with a Palliative Care Intervention for Patients with Advanced Heart Failure: Insights from PAL-HF. (2021) (0)
Abstract 14837: Social Determinants of Health and Outcomes in Patients With Advanced Heart Failure: Findings From PAL-HF (2020) (0)
Quality of life outcomes in acute coronary syndromes: reasons why non-ST elevation patients do worse (2002) (0)
Erratum: How to become a cardiovascular investigator (Journal of the American College of Cardiology (October 4, 2005) SUPPL. A)) (2005) (0)
Long-Term Mortality of Patients With Acute Myocardial Infarction in the United States and Canada Comparison of Patients Enrolled in Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries (GUSTO)-I of declining mortality (2004) (0)
Do ICDs alter the location of death in heart failure patients (2005) (0)
Degree of baseline risk should, but does not, influence treatment decisions in non-ST elevation acute coronary syndromes: Evidence from international clinical trials (2003) (0)
Incidence, mechanisms and duration of inappropriate mode switching in ADEPT (advanced elements of pacing trial) (2005) (0)
WOULD OBSERVATIONAL DATA HAVE PREDICTED RESULTS FOUND IN RANDOMIZED CONTROLLED TRIALS OF CORONARY REVASCULARIZATION (2010) (0)
TCT-284 Comparison of Visual Assessment of Coronary Stenosis with Independent Quantitative Coronary Angiography: Findings from the PROMISE Trial (PROspective Multicenter Imaging Study for Evaluation of chest pain) (2015) (0)
Cost-effectiveness Analysis Of Non-invasive Testing Strategies For Stable Chest Pain Evaluation - Comparison Of Functional Testing, Coronary CTA, And Non-invasive FFRCTBased On The PROMISE Trial (2020) (0)
Optimal Medical Therapy in Heart Failure: Reasons for Lack of Medication Titration in the GUIDE IT Trial (2019) (0)
Abstract 16911: Behind the Looking Glass: Comparing Time to First Event versus Multiple Events Analyses in a Post-myocardial Infarction Clinical Trial (2015) (0)
DIFFERENCES BETWEEN BLACK AND WHITE AMERICANS WITH STABLE CHEST PAIN: ASCVD RISK SCORE, CORONARY ARTERY DISEASE AND CARDIAC EVENTS IN PROMISE (PROSPECTIVE MULTICENTER IMAGING STUDY FOR EVALUATION OF CHEST PAIN) (2019) (0)
3209High-risk coronary plaque is an independent predictor of major adverse cardiovascular events in patients with stable chest pain: Results from PROMISE (2017) (0)
A New Prognostic Treadmill Score Stratifies Risk in Outpatients (1990) (0)
Abstract 4708: Cost-effectiveness of an Early Revascularization Strategy for Cardiogenic Shock Based on Long-term Outcomes (2009) (0)
PCV60 ECONOMIC ANALYSIS OF ENDEAVOR VS. CYPHER STENTS: RESULTS FROM THE ENDEAVOR III TRIAL (2009) (0)
Impact of treatment strategies for AF on the progression and regression of AF type in the CABANA trial (2020) (0)
Clinical Investigations Bimodal Distribution of Atrial Fibrillation Burden in 3 Distinct Cohorts: What is ‘Paroxysmal’ Atrial Fibrillation? (2021) (0)
484Impact of AF type on the outcome of atrial fibrillation ablation: insights from the CABANA trial (2019) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Daniel B. Mark?

Daniel B. Mark is affiliated with the following schools:

Daniel B. Mark's Academic­Influence.com Rankings

Daniel B. Mark's Degrees

Similar Degrees You Can Earn

Why Is Daniel B. Mark Influential?

Daniel B. Mark's Published Works

Published Works

What Schools Are Affiliated With Daniel B. Mark?

Daniel B. Mark's AcademicInfluence.com Rankings